AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting

Start with:

✓7-day trial • $39/mo or $29/mo annual

✓AI + proprietary hiring database

✓Executive contact details included

INDUSTRY FIRST

Ora, Inc. Appoints Nate Speicher As Chief Financial Officer

Jun 28, 2023•about 2 years ago

Position

Chief Financial Officer

Company

Ora, Inc.

Nate Speicher

AndoverInformation Technology

Description

Ora, Inc., the world’s leading Clinical Research Organization for ophthalmology pharmaceutical and device development, announced today that Nate Speicher has been appointed Chief Financial Officer . An experienced CFO leader, Nate will report directly to Chairman & CEO, Stuart Abelson.

Company Information

Company

Ora, Inc.

Location

960 MOUNTAIN VIEW BLVD SE

Andover, Massachusetts, United States

About

Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 50 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.

Company News

(8 articles)

Fri, 19 Jul 2024 07:00:00 GMT

Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research - Business Wire

Wed, 12 Jul 2023 07:00:00 GMT

Ora, Inc. Partners with the North West London Clinical Trials Alliance to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments - Business Wire

Wed, 29 Mar 2017 07:00:00 GMT

Ophthalmic CRO Ora kept in ocular clinical trial pact with Axim - Fierce Biotech

Tue, 25 Feb 2025 08:00:00 GMT

DIAGNOS to File for FDA Pre-Market Authorization of Its - GlobeNewswire

Tue, 22 Oct 2024 07:00:00 GMT

Ora Strengthens Global Leadership with Key Appointments in Europe and People Services - Business Wire

Wed, 28 Jun 2023 07:00:00 GMT

Ora, Inc. Appoints Nate Speicher as Chief Financial Officer - Business Wire

Thu, 05 Sep 2024 07:00:00 GMT

Ora Partners with the Institute of Eye Surgery to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments - Business Wire

Mon, 04 Mar 2024 08:00:00 GMT

SDC Optimizes Focus on Tech-Enabled Biometric Services - Business Wire

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months